Trending
Health

Genetically Modified Pig Kidney Kept US Man Off Dialysis for Record Nine Months — Lancet Study

A 66-year-old American man went 271 days without dialysis after receiving a genetically engineered pig kidney, in what researchers describe as the first successful use of an animal organ as a "bridge" to a human kidney transplant.

Eromsele Samuel · · 181
Kidney Transplant

A genetically modified pig kidney kept a 66-year-old American man free of dialysis for a record 271 days, in what researchers describe as the first successful use of a pig organ as a temporary "bridge" toward a subsequent human kidney transplant.


Findings from the case, published in a new report in The Lancet, offer fresh hope for the growing number of patients worldwide who face long waiting times for human organs amid a persistent global shortage of donor kidneys.


The patient, who was living with kidney failure caused by type 2 diabetes, had already spent two years on haemodialysis, a medical treatment that uses a specialised machine to filter waste products, excess fluid, and toxins from the blood when the kidneys can no longer perform that function, before receiving the pig organ in January 2025.


According to the study, the man's prospects of receiving a human kidney through conventional means were bleak. Based on the Kidney Transplant Decision Tool, a programme used to weigh treatment options and estimate waiting times, his estimated probability of receiving a matching human kidney was only around 9 per cent, while his estimated risk of dying or being removed from the transplant waiting list altogether exceeded 40 per cent.


Given those odds, doctors proceeded with the experimental pig kidney transplant. The organ, sourced from a Yucatan miniature pig, was genetically engineered with 69 distinct genomic modifications specifically designed to improve its compatibility and safety within a human body. According to the researchers, the transplanted kidney began functioning immediately after the procedure, successfully providing dialysis-free kidney support for 271 days, a record for this kind of cross-species "bridge" transplant.


Around six months after the transplant, however, damage began developing in the blood vessels of the pig kidney, eventually progressing to organ failure. The kidney was removed roughly nine months after it was first transplanted. Notably, researchers found that the patient did not develop the antibodies against animal tissue that would typically be expected in such cases, antibodies that, had they developed, could have significantly complicated his ability to subsequently accept a human kidney. He also showed no signs of any animal-borne infections following the procedure.


After the pig kidney was extracted, the patient returned briefly to dialysis before going on to receive a human kidney transplant from a deceased donor. Following that second transplant, doctors reported that his kidney function has remained stable.


The case adds to a small but rapidly growing body of clinical experience with xenotransplantation, the use of animal organs, cells, or tissues to treat human patients, an area of medicine that had for decades been held back by the human immune system's tendency to violently reject foreign animal tissue. Advances in genetic engineering over the past several years have allowed researchers to modify pig organs to more closely resemble human tissue, reviving hope that such organs could eventually help ease chronic global shortages of donor kidneys, hearts, and other organs.


Previous xenotransplant cases in the United States have produced a range of outcomes. Some patients have lived with functioning pig kidneys for periods ranging from just over four months to more than seven months, while earlier experimental transplants, including two pig heart transplants and additional pig kidney procedures, generally proved shorter-lived. Researchers involved in these various trials have consistently stressed that each case, whatever its ultimate outcome, contributes valuable data toward eventually making xenotransplantation a safe, viable, and more widely available treatment option.


With more than 100,000 people currently on organ transplant waiting lists in the United States alone, the majority of them in need of kidneys, researchers say cases like this latest one offer a meaningful proof of concept: that a genetically modified pig kidney can successfully serve as a functional, dialysis-free bridge, buying critically ill patients precious time while they wait for a suitable human donor organ to become available.


Sponsored

Sponsored content
Share this story

Comments (0)

  1. Be the first to share your thoughts.

Leave a comment

All comments are moderated before publishing. Your email is never published.

Not published.

Related stories

Nigeria Unveils Second Robotic Surgery Platform in Northern Region Health

Nigeria Unveils Second Robotic Surgery Platform in Northern Region

The Federal Government has unveiled Nigeria’s second robotic surgery platform at Eleos Specialist Hospital, Abuja—a milestone that places the country’s capital at the forefront of advanced medical technology in Northern Nigeria. With precision surgery, reduced recovery times, and improved patient outcomes, the platform signals a new era in Nigerian healthcare. But with cost, access, and training still looming large, the question is whether this is a genuine transformation or a gleaming showpiece

Nov 20, 2026
JOHESU Gives FCTA Seven-Day Ultimatum Over Unpaid Health Workers’ Allowances Health

JOHESU Gives FCTA Seven-Day Ultimatum Over Unpaid Health Workers’ Allowances

The Joint Health Sector Unions (JOHESU) has issued a seven-day ultimatum to the Federal Capital Territory Administration (FCTA) to pay outstanding allowances owed to health workers or face an indefinite strike that would paralyse Abuja’s hospitals and clinics. The ultimatum, which expires on November 27, 2026, follows the expiration of a previous 14-day warning and a FCT Minister’s directive that remains unimplemented. With CONHESS adjustment arrears, skipping allowances, and promotion arrears s

Nov 20, 2026
FESTAC Fit Walk 2026 Turns Lagos Streets Into Fitness Hub, Free Clinic Health

FESTAC Fit Walk 2026 Turns Lagos Streets Into Fitness Hub, Free Clinic

ShakaraSquare’s 2026 Festac Fit Walk brought residents, Nollywood actor Seun Akindele, Peninsula Medicare, and a coalition of corporate partners together for a day of fitness and free health screenings,blood pressure, blood sugar, eye exams, and dental checks,in a deliberate attempt to shift Lagos’ health conversation from costly cure to accessible prevention. With Festival Mall as the finish line and Prospera Finance linking wellness to financial responsibility, the event was part fitness festi

Nov 20, 2026
Manipal Hospitals Opens Lagos Centre to Attract Nigerian Medical Travellers Health

Manipal Hospitals Opens Lagos Centre to Attract Nigerian Medical Travellers

Indian healthcare powerhouse Manipal Hospitals has opened a patient information centre in Ikeja GRA, Lagos, in partnership with LinkMi Nigeria, offering Nigerian patients access to online consultations, medical visa support, travel arrangements, and follow-up care across its 50-hospital network in India. With over 11,000 doctors, 55 specialties, and robotic-assisted surgery capabilities, the move signals a deepening competition for Nigeria’s medical tourism spending,and a tacit admission that th

Nov 20, 2026